From US$ 1.74 Billion in 2024 to US$ 5.76 Billion by 2031 Market Growth
The market is benefiting from increased research in genetic disorders and oncology therapies.Viral vectors play a critical role in targeted gene delivery and therapeutic innovation.Demand for reliable manufacturing services continues to rise across research and clinical sectors. Viral Vector Manufacturing Market to Hit US$ 5.76B by 2031 The Viral Vector Manufacturing Market is experiencing...
0 Commentaires 0 parts